News

As per the deal, AMRI will be the primary manufacturer and supplier of Rev7, AGC and other polymers present in Rev7 degradable gum products. The agreement will be

One patent has been awarded to the company’s Recall-Vax technology and the second patent has been granted for IN-N01. Recall-Vax is an active vaccine intended to generate highly

Colcrys is used for the prophylaxis and treatment of gout flares, besides Familial Mediterranean Fever (FMF). In the study, ‘Colchicine Dosing Guidance for Gout Patients with Varying Degrees

The trial will involve 2,600 patients with a history of chronic angina who have incomplete revascularization following percutaneous coronary intervention (PCI). Ranolazine is an extended-release tablet approved under

The Phase 3 trial includes two double-blind vehicle-controlled trials with two-to-one randomisation between Tavaborole and vehicle (the topical formulation without the active ingredient). Anacor Pharmaceuticals CEO David Perry

Vivitrol is a once-monthly, extended-release injectable naltrexone medication, used to treat alcohol dependence and opioid dependence. As measured by the number of opioid-free urine screens, Vivitrol along with

The contraceptive has received FDA approval for the prevention of pregnancy in women for up to three years. Nexplanon should be removed by the end of the third

The agreement signed in December 2009 for a period of two years, has been extended by Bristol-Myers Squibb for an additional six months term to June 2012. As

As per the agreement, both the companies will develop multi-specific products with extended half-lives, by exploiting the features of Nanobody. Ablynx will receive an upfront payment of EUR20m